Lifecore Capital Stock from 2010 to 2025

LFCR Stock

6.60 0.05 0.76%

Lifecore Biomedical Capital Stock yearly trend continues to be relatively stable with very little volatility. Capital Stock is likely to drop to about 32.5 K. Capital Stock is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. View All Fundamentals

Capital Stock

First Reported

2010-12-31

Previous Quarter

34.5 K

Current Value

32.5 K

Quarterly Volatility

1.6 K

Credit Downgrade

Yuan Drop

Covid

Check Lifecore Biomedical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lifecore Biomedical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 6.4 M, Interest Expense of 21.8 M or Total Revenue of 140.1 M, as well as many indicators such as Price To Sales Ratio of 0.2, Dividend Yield of 0.0 or PTB Ratio of 0.74. Lifecore financial statements analysis is a perfect complement when working with Lifecore Biomedical Valuation or Volatility modules.

Check out the analysis of Lifecore Biomedical Correlation against competitors.

To learn how to invest in Lifecore Stock, please use our How to Invest in Lifecore Biomedical guide.

Latest Lifecore Biomedical's Capital Stock Growth Pattern

Below is the plot of the Capital Stock of Lifecore Biomedical over the last few years. It is the total amount of a company's capital funded by shareholders through the issue and subscription of shares. Lifecore Biomedical's Capital Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lifecore Biomedical's overall financial position and show how it may be relating to other accounts over time.

Capital Stock

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Capital Stock

Timeline

Lifecore Capital Stock Regression Statistics

	Arithmetic Mean	29,747
	Geometric Mean	29,711
	Coefficient Of Variation	5.22
	Mean Deviation	1,027
	Median	29,000
	Standard Deviation	1,554
	Sample Variance	2.4M
	Range	5.5K
	R-Value	0.68
	Mean Square Error	1.4M
	R-Squared	0.46
	Significance	0
	Slope	220.96
	Total Sum of Squares	36.2M

Lifecore Capital Stock History

	2025	32.5 K
	2024	34.5 K
	2021	30 K

Other Fundumenentals of Lifecore Biomedical

Issuance Of Capital Stock

Lifecore Biomedical Capital Stock component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Short Term Debt	Net Receivables	Intangible Assets	Common Stock	Current Deferred Revenue	Short Term Investments	Good Will	Net Tangible Assets	Long Term Debt	Net Invested Capital	Long Term Investments	Short Long Term Debt	Capital Stock	Net Working Capital	Property Plant Equipment
Total Assets		0.76	0.62	0.48	0.75	0.69	0.85	0.4	0.89	0.31	-0.66	-0.48	-0.66	0.69	0.24	0.21	0.25	0.04	0.26	-0.2	-0.08	0.15
Total Stockholder Equity	0.76		0.0	0.91	0.8	0.08	0.45	0.17	0.77	0.63	-0.42	-0.46	-0.64	0.89	0.72	-0.34	0.71	0.63	0.69	-0.61	-0.6	0.66
Net Debt	0.62	0.0		-0.28	0.16	0.94	0.84	0.56	0.46	-0.31	-0.41	-0.21	-0.24	0.02	-0.44	0.67	-0.41	-0.67	-0.38	0.31	0.6	-0.53
Retained Earnings	0.48	0.91	-0.28		0.6	-0.27	0.22	0.11	0.52	0.72	-0.09	-0.38	-0.46	0.87	0.9	-0.55	0.87	0.83	0.86	-0.82	-0.75	0.83
Accounts Payable	0.75	0.8	0.16	0.6		0.32	0.48	0.2	0.89	0.53	-0.5	-0.46	-0.54	0.71	0.4	-0.33	0.48	0.48	0.57	-0.28	-0.56	0.58
Total Liab	0.69	0.08	0.94	-0.27	0.32		0.78	0.38	0.53	-0.22	-0.57	-0.25	-0.3	0.09	-0.43	0.69	-0.37	-0.62	-0.37	0.4	0.49	-0.48
Total Current Assets	0.85	0.45	0.84	0.22	0.48	0.78		0.69	0.76	0.16	-0.56	-0.47	-0.56	0.39	-0.02	0.35	-0.05	-0.29	0.03	-0.08	0.28	-0.15
Short Term Debt	0.4	0.17	0.56	0.11	0.2	0.38	0.69		0.44	-0.03	-0.2	-0.33	-0.31	0.05	-0.21	-0.03	-0.26	-0.19	-0.05	-0.13	0.29	-0.09
Net Receivables	0.89	0.77	0.46	0.52	0.89	0.53	0.76	0.44		0.34	-0.66	-0.53	-0.69	0.6	0.25	-0.14	0.27	0.19	0.41	-0.22	-0.25	0.32
Intangible Assets	0.31	0.63	-0.31	0.72	0.53	-0.22	0.16	-0.03	0.34		-0.19	-0.48	-0.43	0.68	0.71	-0.39	0.69	0.65	0.66	-0.59	-0.61	0.65
Common Stock	-0.66	-0.42	-0.41	-0.09	-0.5	-0.57	-0.56	-0.2	-0.66	-0.19		0.5	0.83	-0.16	0.17	-0.17	0.17	0.21	0.16	-0.13	-0.19	0.18
Current Deferred Revenue	-0.48	-0.46	-0.21	-0.38	-0.46	-0.25	-0.47	-0.33	-0.53	-0.48	0.5		0.57	-0.41	-0.24	0.18	-0.25	-0.19	-0.31	0.26	0.18	-0.25
Short Term Investments	-0.66	-0.64	-0.24	-0.46	-0.54	-0.3	-0.56	-0.31	-0.69	-0.43	0.83	0.57		-0.39	-0.18	0.13	-0.14	-0.13	-0.18	0.42	0.06	-0.14
Good Will	0.69	0.89	0.02	0.87	0.71	0.09	0.39	0.05	0.6	0.68	-0.16	-0.41	-0.39		0.81	-0.19	0.83	0.66	0.75	-0.63	-0.66	0.71
Net Tangible Assets	0.24	0.72	-0.44	0.9	0.4	-0.43	-0.02	-0.21	0.25	0.71	0.17	-0.24	-0.18	0.81		-0.49	0.97	0.85	0.91	-0.77	-0.81	0.84
Long Term Debt	0.21	-0.34	0.67	-0.55	-0.33	0.69	0.35	-0.03	-0.14	-0.39	-0.17	0.18	0.13	-0.19	-0.49		-0.47	-0.8	-0.65	0.53	0.73	-0.76
Net Invested Capital	0.25	0.71	-0.41	0.87	0.48	-0.37	-0.05	-0.26	0.27	0.69	0.17	-0.25	-0.14	0.83	0.97	-0.47		0.87	0.91	-0.72	-0.88	0.87
Long Term Investments	0.04	0.63	-0.67	0.83	0.48	-0.62	-0.29	-0.19	0.19	0.65	0.21	-0.19	-0.13	0.66	0.85	-0.8	0.87		0.88	-0.72	-0.96	0.97
Short Long Term Debt	0.26	0.69	-0.38	0.86	0.57	-0.37	0.03	-0.05	0.41	0.66	0.16	-0.31	-0.18	0.75	0.91	-0.65	0.91	0.88		-0.72	-0.9	0.94
Capital Stock	-0.2	-0.61	0.31	-0.82	-0.28	0.4	-0.08	-0.13	-0.22	-0.59	-0.13	0.26	0.42	-0.63	-0.77	0.53	-0.72	-0.72	-0.72		0.59	-0.71
Net Working Capital	-0.08	-0.6	0.6	-0.75	-0.56	0.49	0.28	0.29	-0.25	-0.61	-0.19	0.18	0.06	-0.66	-0.81	0.73	-0.88	-0.96	-0.9	0.59		-0.97
Property Plant Equipment	0.15	0.66	-0.53	0.83	0.58	-0.48	-0.15	-0.09	0.32	0.65	0.18	-0.25	-0.14	0.71	0.84	-0.76	0.87	0.97	0.94	-0.71	-0.97

Click cells to compare fundamentals

About Lifecore Biomedical Financial Statements

Lifecore Biomedical shareholders use historical fundamental indicators, such as Capital Stock, to determine how well the company is positioned to perform in the future. Although Lifecore Biomedical investors may analyze each financial statement separately, they are all interrelated. The changes in Lifecore Biomedical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Lifecore Biomedical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.

		Last Reported	Projected for Next Year
	Capital Stock	34.5 K	32.5 K

Additional Tools for Lifecore Stock Analysis

When running Lifecore Biomedical's price analysis, check to measure Lifecore Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifecore Biomedical is operating at the current time. Most of Lifecore Biomedical's value examination focuses on studying past and present price action to predict the probability of Lifecore Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifecore Biomedical's price. Additionally, you may evaluate how the addition of Lifecore Biomedical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Lifecore Capital Stock from 2010 to 2025

Latest Lifecore Biomedical's Capital Stock Growth Pattern

Lifecore Capital Stock Regression Statistics

Lifecore Capital Stock History

Other Fundumenentals of Lifecore Biomedical

Lifecore Biomedical Capital Stock component correlations

About Lifecore Biomedical Financial Statements

Additional Tools for Lifecore Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY